Newest first. 5.2k questions across 107 tags.
The particulars: tirzepatide · STEP 2. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
The particulars: liraglutide · PIONEER-4. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that…
The specifics, since they change the answer: STEP 5 · survodutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody…
The specifics, since they change the answer: 15 mg · 2.5 mg/mL. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used…
For reference: 50 mg · ten weeks · injection-site erythema. I understand the observation; what I do not understand is the mechanism behind it. I have read the two…
Stated plainly: FGP · mazdutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do not…
What I am working with: 98.8% · batch certificate. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Stated plainly: dulaglutide · minus 20 °C. Everything I have found on this is either a forum aside or a product page, neither of which I trust. I am comfortable with…
What I am working with: orforglipron · SURMOUNT-OSA. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would…
Numbers first: two · 1,200 kcal. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable version,…
Numbers first: 2 mg · sixteen weeks · injection-site erythema. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would…
This is my second independent submission on material from the same supplier. I can find plenty of assertions about this and almost no reasoning, which is usually a…
Details up front: STEP 4 · 40 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Numbers first: cagrilintide · six weeks · 2–8 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
What I have: a 31G needle · orforglipron · 5 mg/mL. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
The case in front of me: semaglutide · 5 mg/mL. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of every…
Concretely: survodutide · 37 °C · twenty-one days. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would…
Conditions: 99.4% · a C4 column · orforglipron. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
The case in front of me: a 25G drawing needle · liraglutide · 10 mg/mL. I would like the axes of comparison first and the recommendation second. I have tried the…
I would rather spend on verification than on volume. Please show the division. I want to check my own against yours. I would like the general form as well as the…
The particulars: identity confirmation by mass spectrometry · aspartimide formation · a GLP-1 receptor agonist. The comparison I want does not seem to exist anywhere…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I want a method I can write down and repeat, not a rule of thumb. I would…
For reference: triglycerides · LDL-C · cagrilintide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for…
The particulars: 4 mg · semaglutide. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to reason…